Novel rapid- and short-acting hypoglycemic agent, a calcium(2s)-2-benzyl-3-(cis-hexahydro-2-isoindolinylcarbonyl) propionate (KAD-1229) that acts on the sulfonylurea receptor: comparison of effects between KAD-1229 and gliclazide - Ohnota, H; Koizumi, T; Tsutsumi, N (J Pharmacol Exp Ther, 1994)
et al.